Business Wire

UAE's Technology Innovation Institute Launches Open-Source "Falcon 40B" Large Language Model for Research & Commercial Utilization

Share

The Technology Innovation Institute (TII), a leading global scientific research center and the applied research pillar of Abu Dhabi’s Advanced Technology Research Council (ATRC), today strengthened its growing international influence in the field of artificial intelligence by announcing that "Falcon 40B," the UAE's first large-scale AI model, is now open source for research and commercial use. This pioneering move demonstrates Abu Dhabi's commitment to fostering collaboration across sectors and driving advancements in generative AI.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230525005043/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

"Falcon 40B," the UAE's first large-scale AI model, is now open source for research and commercial use. (Photo: AETOSWire)

Falcon, a foundational large language model (LLM) with 40 billion parameters, trained on one trillion tokens, grants unprecedented access to researchers and small and medium-sized enterprise (SME) innovators alike. TII is providing access to the model’s weights as a more comprehensive open-source package, with the aim of enabling access to powerful LLM capabilities, promoting transparency and accountability, and supporting innovation and research in the field.

In the current AI ecosystem, developers are finding LLMs that provide access to model weights more appealing due to the enhanced capabilities they offer for fine-tuning compared to those without. While the majority of LLMs have granted exclusive licenses solely to non-commercial users, TII has taken a key stride in offering researchers and commercial users access to the Falcon 40B LLM.

In conjunction with the release of Falcon 40B as an open-source model, TII has launched a call for proposals, inviting scientists, researchers, and visionaries who are enthusiastic about harnessing the potential of the foundation model. They are encouraged to contribute their innovative ideas and leverage the model to build inspiring use cases or explore further possibilities for its application to cover areas like engineering, healthcare, sustainability, coding, and much more.

As an incentive for exceptional research proposals, selected projects will receive “training compute power” in the form of investment, enabling innovators to leverage robust computational resources for accelerated data analysis, complex modeling, and new discoveries. This support will nurture and accelerate the development of novel ideas, providing the necessary resources to turn them into impactful AI solutions with commercial viability and societal benefits.

VentureOne, the commercialization arm of ATRC, will facilitate computation power to productize the most innovative solutions.

"Making Falcon 40B open source represents a critical milestone in our commitment to fostering AI innovation," said H.E.Faisal Al Bannai, Secretary General of the Advanced Technology Research Council (ATRC). "We are disrupting LLM access and enabling researchers and entrepreneurs to come up with the most innovative use cases. We will further support these submissions with computation power as funding through VentureOne, helping to advance a thriving research ecosystem.”

Falcon, first unveiled in March 2023, showcased exceptional performance and underscored the UAE's commitment to technological progress. Based on Stanford University’s HELM LLM benchmarking tool, Falcon 40B outperformed its renowned counterparts in utilizing significantly less training compute power. With only 75 percent of the training compute of OpenAI's GPT-3, 40 percent of DeepMind's Chinchilla AI, and 80 percent of the training compute of Google's PaLM-62B, the tool substantiated TII's commitment to advancing developments in generative AI.

Dr. Ray O. Johnson, CEO of TII, said: "Computing power plays a pivotal role in expediting AI system training and enabling faster implementation of use cases. As the new fuel that drives technological innovation, the move to offer such support will be game-changing in enhancing the capabilities of innovators, and enabling them to push the boundaries of their projects to achieve remarkable advancements."

Falcon 40B is a breakthrough led by TII’s AI and Digital Science Research Center (AIDRC). The same team also launched NOOR, the world’s largest Arabic NLP model last year, and is on track to develop and announce Falcon 180B soon.

Dr. Ebtesam Almazrouei Director, AI Cross-Center Unit, TII, said: “The open-source release of Falcon 40B, 7.5B, and 1.3B parameter AI models and our high-quality REFINEDWEB dataset, exemplifies the profound scientific contributions of the UAE. With each breakthrough, we defy limitations, reshape the realm of possibilities, and pave the way for collaborative efforts with transformative impact."

The UAE recently moved up five places to rank as the top Arab country and the 37th out of 166 countries in the UN Frontier Technologies Readiness Index 2023. Complementing a long list of progressive technology milestones, the open-source generative AI model is set to boost the UAE’s credentials as a mainstream AI player.

If you are interested in accessing the Falcon AI models or submitting for the use case call for proposal, we invite you to visit FalconLLM.TII.ae. Falcon LLMs open sourced to date, will be made available under a license built upon the principles of open-source Apache 2.0 software, which allows for a wide range of free use.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jennifer Dewan, Senior Director of Communications
jennifer.dewan@tii.ae.

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 11:00:00 EET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in

Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 11:00:00 EET | Press release

Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration

Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 11:00:00 EET | Press release

Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 10:00:00 EET | Press release

Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of

Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 09:44:00 EET | Press release

Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye